Studying the impact of comorbidity on post radical cystectomy survival: have we come a full circle?

The importance of comorbidity on the survival outcomes of any major surgery cannot be understated. Furthermore, the impact of one or more significant medical comorbidities on an inherently morbid procedure such as radical cystectomy is all but obvious.

• Publication year

  2019

• Venue

  Translational Andrology and Urology

• Publication date

  2019-06-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.21037/TAU.2019.06.06PMID 31392156PMCID PMC6642976
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association Between Preoperative Hydronephrosis and Prognosis After Radical Cystectomy Among Patients With Bladder Cancer: A Systemic Review and Meta-Analysis

  2019cited by this paper
• Development of a New Comorbidity Assessment Tool for Specific Prediction of Perioperative Mortality in Contemporary Patients Treated with Radical Cystectomy

  2019cited by this paper
• Frailty as a predictor of complications after radical cystectomy: A prospective study of various preoperative assessments.

  2019cited by this paper
• Systematic Review of Comorbidity and Competing-risks Assessments for Bladder Cancer Patients.

  2018cited by this paper
• Staging the Host: Personalizing Risk Assessment for Radical Cystectomy Patients.

  2018cited by this paper
• Complications within 90 days after radical cystectomy for bladder cancer: results of a multicenter prospective study in Japan

  2018cited by this paper
• Burden of Multiple Chronic Conditions among Patients with Urological Cancer

  2018cited by this paper
• Discriminative Ability of Commonly Used Indexes to Predict Adverse Outcomes After Radical Cystectomy: Comparison of Demographic Data, American Society of Anesthesiologists, Modified Charlson Comorbidity Index, and Modified Frailty Index

  2018cited by this paper
• Underutilization of Radical Cystectomy Among Patients Diagnosed with Clinical Stage T2 Muscle-invasive Bladder Cancer.

  2017cited by this paper
• Prospects and progress of immunotherapy for bladder cancer

  2017cited by this paper
• Cancer and All-cause Mortality in Bladder Cancer Patients Undergoing Radical Cystectomy: Development and Validation of a Nomogram for Treatment Decision-making.

  2017cited by this paper
• Short-Form Charlson Comorbidity Index for Assessment of Perioperative Mortality After Radical Cystectomy.

  2017cited by this paper
• Exercise-based pre-habilitation is feasible and effective in radical cystectomy pathways—secondary results from a randomized controlled trial

  2016cited by this paper
• Mortality after radical cystectomy: impact of obesity versus adiposity after adjusting for skeletal muscle wasting.

  2015cited by this paper
• Lee mortality index as comorbidity measure in patients undergoing radical cystectomy

  2015cited by this paper
• Association of hospital volume with conditional 90‐day mortality after cystectomy: an analysis of the National Cancer Data Base

  2014cited by this paper
• Peri-Operative Morbidity Associated with Radical Cystectomy in a Multicenter Database of Community and Academic Hospitals

  2014cited by this paper
• Lower skeletal muscle index and early complications in patients undergoing radical cystectomy for bladder cancer

  2014cited by this paper
• The SPARC score: a multifactorial outcome prediction model for patients undergoing radical cystectomy for bladder cancer.

  2013cited by this paper
• Comparative performance of comorbidity indices for estimating perioperative and 5-year all cause mortality following radical cystectomy for bladder cancer.

  2013cited by this paper
• Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder.

  2012cited by this paper
• Malnutrition and clinical outcome in urological patients

  2011cited by this paper
• Preoperative hydronephrosis as an indicator of survival after radical cystectomy.

  2009cited by this paper
• Hydronephrosis as a prognostic marker in bladder cancer in a cystectomy-only series.

  2007cited by this paper
• Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

  1992cited by this paper

• Radical cystectomy for bladder cancer in Sub-Saharan Africa: techniques, challenges, and survival outcomes: a comprehensive review

  2025cites this paper
• Psoas muscle mass can predict postsurgical outcomes in patients who undergo radical cystectomy and urinary diversion reconstruction.

  2021cites this paper
• Highlighting the road towards new disease-specific comorbidity indices

  2020cites this paper
• Systematic Review of Comorbidity and Competing-risks Assessments for Bladder Cancer Patients.

  2018cites this paper